Literature DB >> 18181084

Polycystic ovary syndrome and endometrial cancer.

Ramesan Navaratnarajah1, Ouma C Pillay, Paul Hardiman.   

Abstract

An association between polycystic ovary syndrome (PCOS) and endometrial carcinoma was first suggested in 1949. Since then, several studies have been published that appear to support this association, and it is common practice among gynecologists and physicians to prescribe hormonal treatment to reduce this perceived risk, although there is no consensus as to the subgroup of PCOS in whom this is required. The mechanism(s) underlying any association are also unclear, but it is again widely assumed that chronic anovulation, which results in continuous estrogen stimulation of the endometrium unopposed by progesterone, is a major factor. However, obesity, hyperinsulinemia, and hyperandrogenism, which are also features of PCOS, are risk factors for endometrial carcinoma, but it does not necessarily follow that the incidence or mortality from endometrial cancer is increased in women with the syndrome. Potential strategies to prevent endometrial cancer in PCOS women are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18181084     DOI: 10.1055/s-2007-992926

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  31 in total

1.  Prospective study of body size throughout the life-course and the incidence of endometrial cancer among premenopausal and postmenopausal women.

Authors:  Marcelle M Dougan; Susan E Hankinson; Immaculata De Vivo; Shelley S Tworoger; Robert J Glynn; Karin B Michels
Journal:  Int J Cancer       Date:  2015-02-05       Impact factor: 7.396

2.  Involvement of Akt, Ras and cell cycle regulators in the potential development of endometrial hyperplasia in women with polycystic ovarian syndrome.

Authors:  A Villavicencio; A Goyeneche; C Telleria; K Bacallao; F Gabler; A Fuentes; M Vega
Journal:  Gynecol Oncol       Date:  2009-07-23       Impact factor: 5.482

Review 3.  Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management.

Authors:  Sinead H McEvoy; Stephanie Nougaret; Nadeem R Abu-Rustum; Hebert Alberto Vargas; Elizabeth A Sadowski; Christine O Menias; Fuki Shitano; Shinya Fujii; Ramon E Sosa; Joanna G Escalon; Evis Sala; Yulia Lakhman
Journal:  Abdom Radiol (NY)       Date:  2017-10

4.  Single-nucleotide polymorphism of INS, INSR, IRS1, IRS2, PPAR-G and CAPN10 genes in the pathogenesis of polycystic ovary syndrome.

Authors:  Maheswari Thangavelu; Usha Rani Godla; F D Paul Solomon; Ravi Maddaly
Journal:  J Genet       Date:  2017-03       Impact factor: 1.166

Review 5.  Polycystic ovary syndrome: etiology, pathogenesis and diagnosis.

Authors:  Mark O Goodarzi; Daniel A Dumesic; Gregorio Chazenbalk; Ricardo Azziz
Journal:  Nat Rev Endocrinol       Date:  2011-01-25       Impact factor: 43.330

6.  Transcriptional profiling with a pathway-oriented analysis identifies dysregulated molecular phenotypes in the endometrium of patients with polycystic ovary syndrome.

Authors:  Jin Yeong Kim; Haengseok Song; Hyunjoo Kim; Hee Jung Kang; Jin Hyun Jun; Sung Ran Hong; Mi Kyoung Koong; In Sun Kim
Journal:  J Clin Endocrinol Metab       Date:  2009-01-13       Impact factor: 5.958

7.  Endometrial carcinoma in a young subfertile woman with polycystic ovarian syndrome.

Authors:  K Jayakrishnan; R Anupama; Aby Koshy; R Raju
Journal:  J Hum Reprod Sci       Date:  2010-01

8.  Cancer risk among infertile women with androgen excess or menstrual disorders (including polycystic ovary syndrome).

Authors:  Louise A Brinton; Kamran S Moghissi; Carolyn L Westhoff; Emmet J Lamb; Bert Scoccia
Journal:  Fertil Steril       Date:  2009-11-25       Impact factor: 7.329

Review 9.  Animal models of the polycystic ovary syndrome phenotype.

Authors:  Vasantha Padmanabhan; Almudena Veiga-Lopez
Journal:  Steroids       Date:  2013-05-20       Impact factor: 2.668

10.  A novel variant of ER-alpha, ER-alpha36 mediates testosterone-stimulated ERK and Akt activation in endometrial cancer Hec1A cells.

Authors:  Sheng-Li Lin; Li-Ying Yan; Xing-Wei Liang; Zhen-Bo Wang; Zhao-Yi Wang; Jie Qiao; Heide Schatten; Qing-Yuan Sun
Journal:  Reprod Biol Endocrinol       Date:  2009-09-24       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.